Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17.
暂无分享，去创建一个
B. Hadaschik | M. Spahn | R. Cathomas | M. Schmid | D. Berthold | S. Rothschild | J. Schardt | U. Petrausch | M. Pless | N. Mach | S. Hayoz | M. Schneider | A. Erdmann | R. Strebel | D. Zihler | Zuzanna Maniecka | S. Aeppli | R. Seiler